Part Details | USP AMITRIPTYLINE HYDROCHLORIDE TABLETS
6505-00-770-2061
Alternate Parts: NDC00228213310, NDC00228-2133-10, NDC00310004110, NDC00310-0041-10, NDC00054404325, NDC00054-4043-25, NDC00603221421, NDC00603-2214-21, NDC00182102001, NDC00182-1020-01, NDC00140010901, NDC00140-0109-01, ENDEP, NDC43567054001, NDC43567-0540-01, NDC00781148801, NDC00781-1488-01, NDC00364057501, NDC00364-0575-01, NDC00310004110, NDC00310-0041-10, NDC00038004110, NDC00038-0041-10, ELAVIL, 6505-00-770-2061, 00-770-2061, 6505007702061, 007702061
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | MAR 15, 1968 | 00-770-2061 | 30902 ( AMITRIPTYLINE HYDROCHLORIDE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-770-2061
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00228-2133-10 | 56287 | ACTAVIS ELIZABETH LLCDBA ACTAVIS US |
NDC00310-0041-10 | 0A273 | ASTRAZENECA LP |
NDC00054-4043-25 | 34471 | BOEHRINGER INGELHEIM ROXANE, INC.DIV SUB OF BOEHRINGER INGELHEIM CORP |
NDC00603-2214-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
NDC00182-1020-01 | 2U436 | GOLDLINE LABORATORIESGOVERNMENT SALES DIV |
NDC00140-0109-01 | 04493 | HOFFMANN-LA ROCHE INC. |
ENDEP | 04493 | HOFFMANN-LA ROCHE INC. |
NDC43567-0540-01 | 6V917 | MD PHARMACEUTICAL CO |
NDC00781-1488-01 | 0THL4 | SANDOZ INC. |
NDC00364-0575-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
NDC00310-0041-10 | 13992 | ZENECA INCZENECA PHARMACEUTICALS GROUP |
NDC00038-0041-10 | 13992 | ZENECA INCZENECA PHARMACEUTICALS GROUP |
ELAVIL | 13992 | ZENECA INCZENECA PHARMACEUTICALS GROUP |
Technical Data | NSN 6505-00-770-2061
Characteristic | Specifications |
---|---|
ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE |
ADMINISTRATION | ORAL |
PRIMARY CONTAINER TYPE | BOTTLE |
PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
THERAPEUTIC EQUIVALENT | ENDEP BY ROCHE |
PART NAME ASSIGNED BY CONTROLLING AGENCY | AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT |